Ritlecitinib

Related records

Trials (53)

• A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2
• A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS.
• A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) Tranquillo
• A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo
• A DRUG-DRUG INTERACTION STUDY BETWEEN PF-06650833 AND PF-06651600 FOLLOWING MULTIPLE DOSES IN HEALTHY PARTICIPANTS
• A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
• A Phase 2b Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Active Non-segmental Vitiligo Subjects
• A Renal Impairment Study for PF-06651600
• A Single Dose Study To Test Two Pediatric Forms Of Ritlecitinib Compared With Adult Ritlecitinib In Healthy Adults
• A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
• A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
• A Study of PF-06651600 Effect on Rosuvastatin Pharmacokinetics in Healthy Participants
• A Study to Assess Two Forms of The Study Medicine (Ritlecitinib) in Healthy Adult Participants
• A STUDY TO ESTIMATE THE EFFECT OF PF-06651600 ON THE PHARMACOKINETICS (PK) OF ORAL CONTRACEPTIVE (OC)
• A STUDY TO EVALUATE THE EFFECT OF PF-06651600 ON PHARMACOKINETICS OF SINGLE DOSE SUMATRIPTAN IN HEALTHY PARTICIPANTS.
• A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of PF-06651600 in Subjects With Hepatic Impairment and Healthy Volunteers
• A Study to Learn About How Different Forms of the Study Medicine Called Ritlecitinib Pass the Intestines of Healthy Male Adults When Taken With or Without Food
• A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata
• A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.
• A Study to Learn About the Medicine Called Ritlecitinib in Adults With Severe Alopecia Areata in Real-world Settings

In development for (15)

• Alopecia areata Phase 3
• Asthma Phase 2
• Celiac disease Phase 2
• Crohn disease Phase 2
• Hidradenitis suppurativa Phase 2
• Keloid Phase 2
• Kidney disorder Phase 1
• Liver disorder Phase 1
• Mycosis fungoides Phase 2
• Pseudopelade of Brocq Phase 2
• Rheumatoid arthritis Phase 2
• Sezary syndrome Phase 2
• Type 1 diabetes mellitus Phase 2
• Ulcerative colitis Phase 2
• Vitiligo Phase 3

Other linked conditions (1)

• Alopecia

Targets (6)

• BMX TEC family kinase inhibitor
• BTK TEC family kinase inhibitor
• ITK TEC family kinase inhibitor
• JAK3 Tyrosine-protein kinase JAK3 inhibitor
• TEC TEC family kinase inhibitor
• TXK TEC family kinase inhibitor